|
Mechanism30S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1981 |
100 Clinical Results associated with Leshan Longmarch Medicine Industry Co Ltd
0 Patents (Medical) associated with Leshan Longmarch Medicine Industry Co Ltd
100 Deals associated with Leshan Longmarch Medicine Industry Co Ltd
100 Translational Medicine associated with Leshan Longmarch Medicine Industry Co Ltd